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Knowing your click from your clunk: Is current DDH screening fit for 
purpose? 
 
In 2000 the journal published an editorial concerning screening in Developmental 
Dysplasia of the Hip (DDH), based on expert opinions from the UK and Sweden1.  
It considered the effectiveness of clinical examination and ultrasound imaging of 
the hip in the screening of pathological DDH.  The conclusion was that the 
effectiveness of hip screening policies for the diagnosis and treatment of DDH was 
unclear. A recent editorial2 in a paediatric journal again raised concerns on the 
efficacy of the current clinical DDH screening programme. 
 
Recently, the Bone and Joint Journal have published long-term observational 
studies casting doubt on the association of pathological DDH with asymmetrical 
skin creases, foot abnormalities and ‘clicky’ hips 3,4,5 each of which have 
contributed to the selective screening programme.  The Newborn Infant Physical 
Examination (NIPE) committee is currently reviewing the screening guidelines for 
diagnosing DDH in England 6. 
 
What has changed since 2000?  The Cochrane review of 2013 7 stated that levels 
of evidence for the effectiveness of screening in DDH are generally poor with no 
improvement in the numbers of late diagnosed DDH requiring surgery since the 
introduction of screening with insufficient evidence to give clear 
recommendations. In 2014, the AAOS 8 in a systematic review, stated that there 
was moderate evidence to reject universal ultrasound screening and that there 
was moderate evidence to undertake an imaging study <6 months of age in cases 
of positive Family History, Breech presentation or history of clinical instability.  
They noted that of the 4026 papers reviewed only 32 had sufficient evidence or 
quality to be used as guidance. 
 
What do we know?  Between 70 to 90% of clinically unstable hip joints will 
stabilise spontaneously between 2 and 4 weeks post-natally 9,10. There is no 
agreement on what constitutes pathological DDH either clinically or 
sonographically. Some research groups consider the majority of Graf Type II hips 
to be pathological, whilst others consider this to be true in only the more severe 
types of sonographic abnormality 11.  There is no robust evidence to confirm that 
the splinting of hip joints in early pathological DDH, is an effective treatment i.e. 
Pavlik harness 1,8. 
 
Are there trends appearing?  The most effective clinical screening programmes 
resulting in the lowest rates of late irreducible hip dislocation appear to be 
delivered by focused clinical screening programmes undertaken by a few well-
trained hip screening health professionals. Studies in Scotland and Sweden 12,13 
have shown improved outcomes when clinical screening is undertaken by small 
groups of experienced health care professionals.  However, the model used in 
many other countries, including the other 3 nations of the UK uses a broad group 
of examiners with variable experience.  This suggests that many of the examiners 
undertaking primary clinical hip screening may be too inexperienced to identify 
the often subtle clinical signs of hip instability, especially given that positive 
instability tests (Ortolani & Barlow manoeuvres 9, 14) are relatively rare11. 
  
 
The significance of ‘clicky’ hips causes considerable debate 4,15. The debate almost 
certainly arises, not because clinicians believe that an innocent click is a true ‘risk 
factor’, but because primary referrers do not know, or cannot differentiate 
between instability and physiological clicking.  The true clinical signs associated 
with pathological DDH appear to be positive Ortolani/Barlow manoeuvres 9,16 and 
unilateral limitation of hip abduction 16: not isolated ‘clicky’ hips or asymmetrical 
skin creases 3,4. 
 
Universal sonographic screening for DDH has been suggested as a solution, though 
this is controversial.  The delayed open reduction rate appears more favourable 
(i.e. lower) for universal sonographic screening than clinical screening or selective 
screening (i.e. targeted sonographic hip screening combined with universal 
clinical hip assessment 17 though this remains the source of debate 7,8. However, 
universal sonographic screening introduces over diagnosis of hip pathology, 
leading to over treatment that could result in long-term complications such as 
avascular necrosis of the femoral head 1.  In some studies up to 7.0% of the 
population may be treated 18.  This is primarily due to the lack of agreement in 
what constitutes true clinical or sonographic hip pathology. 
 
What is the present NIPE policy 19, with possible issues on effectiveness?  
 
1. Neonatal assessment within 48 hours of birth (Ortolani & Barlow manoeuvres), 
with sonographic assessment of positive cases. Relies on the skills/experience of 
current primary clinical hip screeners.  
 
2. ‘At risk’ sonographic screening of ‘at risk’ children with either breech 
presentation or and a strong family history (scan at 4 to 6 weeks). If neonatal hip 
instability is removed from this group, this screening identifies very few positive 
cases of pathological DDH, and fewer in males11. However there is limited evidence 
supporting this arm of screening 8.  
 
3. General Practitioner clinical assessment at 6 weeks of age. The majority of 
positive Ortolani/Barlow hip instability manoeuvres settle by 4 weeks. Unilateral 
Limitation of abduction, as a clinical sign, usually develops at > 3 months of age. 
The timing of the current examination is likely to have a very low yield and recent 
studies dispute its effectiveness 20.  
 
4. Confusing situation on the place of true ‘clicky’ hips or asymmetrical skin 
creases and their association with pathological DDH. There is a poor or absent 
association 3,4. 
 
There is a risk that the current hip-screening regime for DDH is ineffective. It is 
accepted that it fails to meet the criteria of an effective screening programme and 
at best should be regarded as hip surveillance 11. Any national policy will be a 
compromise and the NIPE committee is necessarily an Expert Based Consensus 
model.  Recommendations of this committee are based on the current sub-
optimum DDH screening evidence base.  There is no evidence that the NIPE 
guidelines have reduced the definitive outcome of an irreducible hip dislocation 
  
requiring surgical intervention. A National study comparing contemporary results 
with the 1998 MRC study 21 should be considered to assess the efficacy of NIPE 
policy, or the national neonatal ‘NIPE-Smart’ database should be extended to 
incorporate orthopaedic outcomes to effectively measure the efficacy of the 
programme. 
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